{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T13:47:21Z","timestamp":1706708841485},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T00:00:00Z","timestamp":1396396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12288-014-0370-8","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T04:23:10Z","timestamp":1396326190000},"page":"196-205","source":"Crossref","is-referenced-by-count":3,"title":["Novel Antifungal Drugs Against Fungal Pathogens: Do They Provide Promising Results for Treatment?"],"prefix":"10.1007","volume":"31","author":[{"given":"Habip","family":"Gedik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"\u015eim\u015fek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taner","family":"Y\u0131ld\u0131rmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arzu","family":"Kant\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Ar\u0131ca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demet","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naciye","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Yoku\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"370_CR1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA et al (2011) Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:56\u201393","journal-title":"Clin Infect Dis"},{"key":"370_CR2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1196\/annals.1414.035","volume":"1138","author":"M Ellis","year":"2008","unstructured":"Ellis M (2008) Febrile neutropenia. Ann N Y Acad Sci 1138:329\u2013350","journal-title":"Ann N Y Acad Sci"},{"key":"370_CR3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-86-5-539","volume":"86","author":"J Aisner","year":"1977","unstructured":"Aisner J, Wiernik PH, Schimpf SC (1977) Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 86:539\u2013543","journal-title":"Ann Intern Med"},{"key":"370_CR4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/annonc\/mdq196","volume":"21","author":"J Naurois De","year":"2010","unstructured":"De Naurois J, Novitzky-Basso I, Gill MJ, Marti FM, Cullen MH, Roila F (2010) Management of febrile neutropenia: ESMO clinical practice guidelines. Ann Oncol 21:252\u2013256","journal-title":"Ann Oncol"},{"issue":"10","key":"370_CR5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","volume":"340","author":"TJ Walsh","year":"1999","unstructured":"Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D et al (1999) Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 340(10):764\u2013771","journal-title":"N Engl J Med"},{"key":"370_CR6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","volume":"34","author":"WT Hughes","year":"2002","unstructured":"Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T et al (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730\u2013751","journal-title":"Clin Infect Dis"},{"issue":"1","key":"370_CR7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.2001.19.1.253","volume":"19","author":"D Caillot","year":"2001","unstructured":"Caillot D, Couaillier JF, Bernard A, Casasnovas O, Denning DW, Mannone L et al (2001) Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computerised tomography scans in patients with neutropenia. J Clin Oncol 19(1):253\u2013259","journal-title":"J Clin Oncol"},{"key":"370_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex HB, De Pauw B, Bennett JE, Bille J, Crokaert F et al (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7\u201314","journal-title":"Clin Infect Dis"},{"key":"370_CR9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2141.2004.05140.x","volume":"126","author":"J Maertens","year":"2004","unstructured":"Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, Boogaerts M, Eldere JV (2004) Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 126:852\u2013860","journal-title":"Br J Haematol"},{"issue":"4","key":"370_CR10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1046\/j.1523-1755.2001.00948.x","volume":"60","author":"DW Bates","year":"2001","unstructured":"Bates DW, Su L, Yu DT, Chertow GM, Seger DL, Gomes DR et al (2001) Correlates of acute renal failure in patients receiving parenteral amphotericin B. Kidney Int 60(4):1452\u20131459 (2001)","journal-title":"Kidney Int"},{"issue":"5","key":"370_CR11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/317451","volume":"31","author":"JR Wingard","year":"2000","unstructured":"Wingard JR, White MH, Anaissie E, Raffalli J, Goodman J, Arrieta A, L Amph\/ABLC Collaborative Study Group (2000) A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. Clin Infect Dis 31(5):1155\u20131163","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"370_CR12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/427329","volume":"40","author":"C Viscoli","year":"2005","unstructured":"Viscoli C, Varnier O, Machetti M (2005) Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis 40(Suppl 4):240\u2013245","journal-title":"Clin Infect Dis"},{"key":"370_CR13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00277-002-0466-3","volume":"81","author":"R Martino","year":"2002","unstructured":"Martino R, Subir\u00e0 M (2002) Invasive fungal infections in hematology: new trends. Ann Hematol 81:233\u2013243","journal-title":"Ann Hematol"},{"key":"370_CR14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/ijms13010774","volume":"13","author":"MT Montagna","year":"2012","unstructured":"Montagna MT, Giglio ODG, Napoli C, Lovero G, Caggiano G, Delia M, Pastore D, Santoro N, Specchia G (2012) Invasive fungal infections in patients with hematologic malignancies (aurora project): lights and shadows during 18-months surveillance. Int J Mol Sci 13:774\u2013787","journal-title":"Int J Mol Sci"},{"issue":"12","key":"370_CR15","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1517\/14656566.2012.698263","volume":"13","author":"TB Ng","year":"2012","unstructured":"Ng TB, Cheung RC, Xj Ye, Fang EF, Chan YS, Pan WL, Dan XL et al (2012) Pharmacotherapy approaches to antifungal prophylaxis. Expert Opin Pharmacother 13(12):1695\u20131705","journal-title":"Expert Opin Pharmacother"},{"key":"370_CR16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327\u2013360","journal-title":"Clin Infect Dis"},{"key":"370_CR17","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/AAC.39.9.1907","volume":"39","author":"AM Sugar","year":"1995","unstructured":"Sugar AM (1995) Use of amphotericin B with azole antifungal drugs: what are we doing? Antimicrob Agents Chemother 39:1907\u20131912","journal-title":"Antimicrob Agents Chemother"},{"key":"370_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0732-8893(92)90053-V","volume":"15","author":"DW Denning","year":"1992","unstructured":"Denning DW, Hanson LH, Perlman AM, Stevens DA (1992) In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis 15:21\u201334","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"370_CR19","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cncr.23109","volume":"110","author":"D Caillot","year":"2007","unstructured":"Caillot D, Thi\u00e9baut A, Herbrecht R, de Botton S, Pigneux A, Bernard F et al (2007) Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial). Cancer 110(12):2740\u20132746","journal-title":"Cancer"},{"issue":"1","key":"370_CR20","doi-asserted-by":"crossref","first-page":"e2012011","DOI":"10.4084\/mjhid.2012.011","volume":"4","author":"R Rojas","year":"2012","unstructured":"Rojas R, Molina JR, Jarque I, Montes C, Serrano J, Sanz J, Besalduch J et al (2012) Outcome of antifungal combination therapy for invasive mold infections in hematological patients is independent of the chosen combination. Mediterr J Hematol Infect Dis 4(1):e2012011","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"9","key":"370_CR21","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/jac\/dks189","volume":"67","author":"J Auberger","year":"2012","unstructured":"Auberger J, Lass-Fl\u00f6rl C, Aigner M, Clausen J, Gastl G, Nachbaur D (2012) Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high riskpatients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother 67(9):2268\u20132273","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"370_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1179\/1973947812Y.0000000051","volume":"24","author":"M Mikulska","year":"2012","unstructured":"Mikulska M, Novelli A, Aversa F, Cesaro S, de Rosa FG, Girmenia C et al (2012) Voriconazole in clinical practice. J Chemother 24(6):311\u2013327","journal-title":"J Chemother"},{"issue":"10","key":"370_CR23","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/jac\/dks256","volume":"67","author":"Y Nivoix","year":"2012","unstructured":"Nivoix Y, Launoy A, Lutun P, Moulin JC, Pang KAP, Fornecker LM et al (2012) Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. J Antimicrob Chemother 67(10):2506\u20132513","journal-title":"J Antimicrob Chemother"},{"key":"370_CR24","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","volume":"17","author":"JW Linden van der","year":"2011","unstructured":"van der Linden JW, Snelders E, Kampinga GA, Rijnders BJ, Mattsson E, Debets-Ossenkopp YJ et al (2011) Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007\u20132009. Emerg Infect Dis 17:1846\u20131854","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"370_CR25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMe068266","volume":"356","author":"BE Pauw De","year":"2007","unstructured":"De Pauw BE, Donnelly JP (2007) Prophylaxis and aspergillosis\u2014has the principle been proven? N Engl J Med 356(4):409\u2013411","journal-title":"N Engl J Med"},{"issue":"2","key":"370_CR26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1179\/joc.2011.23.2.92","volume":"23","author":"R Iatta","year":"2011","unstructured":"Iatta R, Caggiano G, Cuna T, Montagna MT (2011) Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia. J Chemother 23(2):92\u201396","journal-title":"J Chemother"},{"issue":"5","key":"370_CR27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12185-008-0184-2","volume":"88","author":"J Auberger","year":"2008","unstructured":"Auberger J, Lass-Fl\u00f6rl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E, Einsele H, Gastl G, Nachbaur D (2008) Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 88(5):508\u2013515","journal-title":"Int J Hematol"},{"issue":"1","key":"370_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/13693786.2011.587211","volume":"50","author":"J Zirkel","year":"2012","unstructured":"Zirkel J, Klinker H, Kuhn A, Abele-Horn M, Tappe D, Turnwald D, Einsele H, Heinz H (2012) Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors. Med Mycol 50(1):50\u201355","journal-title":"Med Mycol"},{"key":"370_CR29","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.1996.14.2.636","volume":"14","author":"JY Blay","year":"1996","unstructured":"Blay JY, Chauvin F, Le Cesne A, Anglaret B, Bouhour D, Lasset C, Freyer G, Philip T, Biron P (1996) Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. J Clin Oncol 14:636","journal-title":"J Clin Oncol"},{"key":"370_CR30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1473-3099(10)70218-8","volume":"11","author":"MH Miceli","year":"2011","unstructured":"Miceli MH, Diaz JA, Lee SA (2011) Emerging opportunistic yeast infections. Lancet Infect Dis 11:142\u2013151","journal-title":"Lancet Infect Dis"},{"key":"370_CR31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1086\/502581","volume":"26","author":"J Morgan","year":"2005","unstructured":"Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S et al (2005) Excess mortality, hospital stay, and cost due to candidemia: a case\u2013control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 26:540\u2013547","journal-title":"Infect Control Hosp Epidemiol"},{"key":"370_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","volume":"51","author":"M Nucci","year":"2010","unstructured":"Nucci M, Anaissie E, Betts RF, Dupont BF, Wu C, Buell DN, Kovanda L, Lortholary O (2010) Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis 51:295\u2013303","journal-title":"Clin Infect Dis"},{"key":"370_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1\u201345","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 7","key":"370_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","volume":"18","author":"AJ Ullmann","year":"2012","unstructured":"Ullmann AJ, Akova M, Herbrecht R, Viscoli C, Arendrup MC, Arikan-Akdagli S, Bassetti M et al (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect 18(Suppl. 7):53\u201367","journal-title":"Clin Microbiol Infect"},{"key":"370_CR35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1099\/jmm.0.46817-0","volume":"56","author":"EM Mokaddas","year":"2007","unstructured":"Mokaddas EM, Noura AZ, Khan U (2007) Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study. J Med Microbiol 56:255\u2013259","journal-title":"J Med Microbiol"},{"key":"370_CR36","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JCM.42.7.3142-3146.2004","volume":"42","author":"MA Pfaller","year":"2004","unstructured":"Pfaller MA, Messer SA, Boyken L, Tendolkar S, Hollis RJ, Diekema DJ (2004) Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS antifungal surveillance program conducted in 2001 and 2002. J Clin Microbiol 42:3142\u20133146","journal-title":"J Clin Microbiol"},{"key":"370_CR37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/423274","volume":"39","author":"A Imhof","year":"2004","unstructured":"Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA (2004) Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 39:743\u2013746","journal-title":"Clin Infect Dis"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-014-0370-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-014-0370-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-014-0370-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T03:17:43Z","timestamp":1565320663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-014-0370-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1007\/s12288-014-0370-8","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,2]]}}}